-
NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab
pharmatimes
August 02, 2021
The UK’s National Institute for Health and Care Excellence (NICE) has published a new guideline of the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) associated with COVID-19 vaccination.
-
FDA grants EUA for Regeneron’s antibody cocktail to prevent Covid-19
pharmaceutical-technology
August 02, 2021
The US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Regeneron Pharmaceuticals’ investigational antibody cocktail, REGEN-COV (casirivimab and imdevimab) to prevent Covid-19.
-
How paperless vaccine passport can become a reality
expresspharma
August 02, 2021
Samarth Bhardwaj, Digital Marketing Head, MSB Docs, explains the ways paperless vaccine passports can provide effortless and seamless travel globally.
-
FDA Broadens Existing Emergency Use of Lilly and Incyte's Baricitinib in Patients Hospitalized with COVID-19 Requiring Oxygen
drugs
August 02, 2021
Eli Lilly and Company and Incyte announced today FDA has broadened the Emergency Use Authorization for baricitinib to allow for treatment with or without remdesivir, whereas the EUA was previously restricted to use only in combination with remdesivir.
-
Israel Offers COVID-19 Booster Shots to Anyone Over 60
drugs
August 02, 2021
Israelis who are over the age of 60 and fully vaccinated against COVID-19 will be offered booster shots, Prime Minister Naftali Bennett said Thursday.
-
Provincetown Outbreak Shows Delta Can Spread Among Vaccinated, But Cases Are Mild
drugs
August 02, 2021
The Cape Cod resort town of Provincetown draws big crowds every summer. In July, those largely vaccinated crowds -- packed into bars, restaurants and private homes -- were the genesis of an outbreak of the Delta variant that could be a sobering model.
-
Affordable Care Act Had Limited Effects on Reducing Uninsurance
drugs
August 02, 2021
There is substantial variation by state in reducing uninsurance for Black, Hispanic, and low-income Americans under the Affordable Care Act (ACA), according to a study published online July 21 in Health Equity.
-
Saudi study documents safety of AstraZeneca
firstwordpharma
August 02, 2021
A study from Saudi Arabia found that no major side effects were associated with AstraZeneca's COVID-19 vaccine AZD1222 and no breakthrough infections were seen, Arab News reported.
-
Research body recommends COVID-19 drug
firstwordpharma
August 02, 2021
Australia's National COVID-19 Clinical Evidence Taskforce issued a new recommendation conditionally backing use of Regeneron's COVID-19 antibody cocktail REGEN-COV (casirivimab/imdevimab), as reported Sunday in This is Money.
-
U.S. approval of COVID-19 shots could boost vaccination numbers, Fauci says
firstwordpharma
August 02, 2021
Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, suggested that full approval of COVID-19 vaccines by the FDA could boost vaccination rates, as reported in Fidelity.